We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$6.05B
AUM Growth
-$355M
Cap. Flow
-$238M
Cap. Flow %
-3.93%
Top 10 Hldgs %
22.18%
Holding
314
New
46
Increased
155
Reduced
70
Closed
36

Top Buys

Rank Stock Value
1
WGS icon
GeneDx Holdings
WGS
+$41.9M
2
GNRC icon
Generac Holdings
GNRC
+$40.9M
3
PCVX icon
Vaxcyte
PCVX
+$24.8M
4
TER icon
Teradyne
TER
+$24.8M
5
ULS icon
UL Solutions
ULS
+$21.1M

Top Sells

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$64.4M
2
GEV icon
GE Vernova
GEV
+$42.1M
3
INSP icon
Inspire Medical Systems
INSP
+$40.6M
4
RNAM
Avidity Biosciences
RNAM
+$37.8M
5
LAD icon
Lithia Motors
LAD
+$33.8M

Sector Composition

Rank Sector Weight
1 Healthcare 39.12%
2 Industrials 19.41%
3 Technology 15.63%
4 Energy 7.14%
5 Consumer Discretionary 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMLX icon
101
Amylyx Pharmaceuticals
AMLX
$4.14B
$21M 0.35%
1,513,958
+810
+0.1% +$11.4K
HUBS icon
102
HubSpot
HUBS
$12.8B
$20.2M 0.33%
82,951
-6,970
-8% -$1.96M
NRIX icon
103
Nurix Therapeutics
NRIX
$2.79B
$20.1M 0.33%
1,297,893
– –
ROK icon
104
Rockwell Automation
ROK
$48.1B
$20.1M 0.33%
56,012
+3,821
+7% +$1.51M
IEX icon
105
IDEX
IEX
$17.2B
$19.1M 0.32%
100,893
+1,758
+2% +$347K
DNTH icon
106
Dianthus Therapeutics
DNTH
$6.24B
$18.9M 0.31%
+225,261
New +$13M
BE icon
107
Bloom Energy
BE
$64.2B
$18.6M 0.31%
137,760
+497
+0.4% +$72.9K
HTFL
108
Heartflow Inc
HTFL
$4.18B
$18.4M 0.3%
756,956
+250,967
+50% +$6.81M
WTW icon
109
Willis Towers Watson
WTW
$31.5B
$18.3M 0.3%
+63,113
New +$19.4M
AJG icon
110
Arthur J. Gallagher & Co
AJG
$66.7B
$18.1M 0.3%
83,670
-56,204
-40% -$13M
AVGO icon
111
Broadcom
AVGO
$1.77T
$17.9M 0.3%
59,117
+11,809
+25% +$3.89M
STRO icon
112
Sutro Biopharma
STRO
$353M
$17.8M 0.29%
+715,307
New +$12.9M
UTHR icon
113
United Therapeutics
UTHR
$22.6B
$16.9M 0.28%
28,552
-18,452
-39% -$9.19M
GRMN
114
Garmin
GRMN
$55.9B
$16.4M 0.27%
70,905
+1,429
+2% +$320K
GKOS icon
115
Glaukos
GKOS
$10.7B
$16.2M 0.27%
150,036
-139,239
-48% -$15.7M
EYPT icon
116
EyePoint Inc
EYPT
$399M
$16.1M 0.27%
+1,245,583
New +$18.6M
FN icon
117
Fabrinet
FN
$15.5B
$16M 0.27%
30,926
+13,917
+82% +$7.07M
DELL icon
118
Dell
DELL
$305B
$16M 0.26%
97,193
+49,461
+104% +$6.59M
MDB icon
119
MongoDB
MDB
$35.4B
$15.3M 0.25%
62,374
+5,773
+10% +$1.93M
PRVA icon
120
Privia Health
PRVA
$2.66B
$15.2M 0.25%
737,694
– –
INTU icon
121
Intuit
INTU
$95.2B
$14.6M 0.24%
33,693
+14,973
+80% +$7.14M
GPI icon
122
Group 1 Automotive
GPI
$3.12B
$14.2M 0.23%
42,837
-20,986
-33% -$7.32M
XYL icon
123
Xylem
XYL
$26.3B
$13.5M 0.22%
113,435
+134
+0.1% +$17.6K
FANG icon
124
Diamondback Energy
FANG
$56.1B
$13.5M 0.22%
67,909
+57,417
+547% +$9.76M
TSM icon
125
TSMC
TSM
$2.22T
$13.4M 0.22%
40,377
+1,955
+5% +$673K
3 4
5
6 7

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Eventide Asset Management held 314 positions worth $6.05B, down 5.5% from $6.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Eventide Asset Management withdrew a net $238M in Q1 2026, closing 36 positions and reducing 70 holdings. Its most notable exit was Inspire Medical Systems, an estimated $40.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Industrials and Technology.

Against the trend, Eventide Asset Management opened a new position in GeneDx Holdings worth $29.5M.

  • Eventide Asset Management's largest Q1 2026 buy was GeneDx Holdings: 459,015 shares worth $29.5M.
  • Eventide Asset Management added most to Generac Holdings in Q1 2026, an estimated $40.9M increase.
  • Eventide Asset Management's biggest Q1 2026 reduction was Mirum Pharmaceuticals, cutting an estimated $64.4M.
  • Eventide Asset Management fully exited Inspire Medical Systems in Q1 2026, selling an estimated $40.6M.
  • Eventide Asset Management's ten largest holdings make up 22% of its $6.05B portfolio in Q1 2026.
  • Eventide Asset Management opened 46 new positions and closed 36 in Q1 2026.
  • Eventide Asset Management's portfolio value fell 5.5% quarter-over-quarter to $6.05B.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.